Creative Medical Technology (CELZ) announced initial data from the first cohort of its ongoing Phase 1/2 clinical trial of CELZ-201-DDT, the ...

Lower back pain is most common in women and is caused by several reasons such as hormonal changes, spine osteoarthritis, ...